Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo F W Soeterik

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
BJU International|February 25, 2021
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imagingTimo F W Soeterik, Tom A Hueting, Bas Israel, et al.
The Journal of Urology|March 29, 2016
Architecture of the Corpus Spongiosum: An Anatomical StudySarah R Ottenhof, Petra de Graaf, Timo F W Soeterik, et al.
Cancers|October 16, 2024
Stereotactic Body Radiotherapy (SBRT) for the Treatment of Primary Localized Renal Cell Carcinoma: A Systematic Review and Meta-AnalysisAgata Suleja, Mateusz Bilski, Ekaterina Laukhtina, et al.
World Journal of Urology|November 7, 2022
A side-specific nomogram for extraprostatic extension may reduce the positive surgical margin rate in radical prostatectomyJoris G Heetman, Timo F W Soeterik, Lieke Wever, et al.
European Urology Oncology|June 9, 2023
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT)Joris G Heetman, Jules Lavalaye, Pepijn D Polm, et al.
European Urology Open Science|April 28, 2025
Personalised Prostate Cancer Diagnosis: Evaluating Biomarker-based Approaches to Reduce Unnecessary Magnetic Resonance Imaging and Biopsy ProceduresTimo F W Soeterik, Xiaobo Wu, Roderick C N Van den Bergh, et al.
European Urology Focus|December 22, 2021
Clinical Trial Protocol for PSMA-SELECT: A Dutch National Randomised Study of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as a Triage Tool for Pelvic Lymph Node Dissection in Patients Undergoing Radical ProstatectomyTimo F W Soeterik, Lieke Wever, Lea M Dijksman, et al.
European Urology Open Science|September 25, 2025
Impact of PARP Inhibitors on Health-related Quality of Life in Patients with Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysisNavid Roessler, Marcin Miszczyk, Akihiro Matsukawa, et al.
Central European Journal of Urology|November 3, 2021
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional studyFabio Zattoni, Giancarlo Marra, Alexander Kretschmer, et al.
The Prostate|May 5, 2024
The additional value of <sup>68</sup>Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsyJoris G Heetman, Leonor J Paulino Pereira, Johannes C Kelder, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
BJU International|February 25, 2021
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imagingTimo F W Soeterik, Tom A Hueting, Bas Israel, et al.
The Journal of Urology|March 29, 2016
Architecture of the Corpus Spongiosum: An Anatomical StudySarah R Ottenhof, Petra de Graaf, Timo F W Soeterik, et al.
Cancers|October 16, 2024
Stereotactic Body Radiotherapy (SBRT) for the Treatment of Primary Localized Renal Cell Carcinoma: A Systematic Review and Meta-AnalysisAgata Suleja, Mateusz Bilski, Ekaterina Laukhtina, et al.
World Journal of Urology|November 7, 2022
A side-specific nomogram for extraprostatic extension may reduce the positive surgical margin rate in radical prostatectomyJoris G Heetman, Timo F W Soeterik, Lieke Wever, et al.
European Urology Oncology|June 9, 2023
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT)Joris G Heetman, Jules Lavalaye, Pepijn D Polm, et al.
European Urology Open Science|April 28, 2025
Personalised Prostate Cancer Diagnosis: Evaluating Biomarker-based Approaches to Reduce Unnecessary Magnetic Resonance Imaging and Biopsy ProceduresTimo F W Soeterik, Xiaobo Wu, Roderick C N Van den Bergh, et al.
European Urology Focus|December 22, 2021
Clinical Trial Protocol for PSMA-SELECT: A Dutch National Randomised Study of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as a Triage Tool for Pelvic Lymph Node Dissection in Patients Undergoing Radical ProstatectomyTimo F W Soeterik, Lieke Wever, Lea M Dijksman, et al.
European Urology Open Science|September 25, 2025
Impact of PARP Inhibitors on Health-related Quality of Life in Patients with Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysisNavid Roessler, Marcin Miszczyk, Akihiro Matsukawa, et al.
Central European Journal of Urology|November 3, 2021
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional studyFabio Zattoni, Giancarlo Marra, Alexander Kretschmer, et al.
The Prostate|May 5, 2024
The additional value of <sup>68</sup>Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsyJoris G Heetman, Leonor J Paulino Pereira, Johannes C Kelder, et al.
Pageof 6